Differentiated thyroid cancer and selenium supplements for protection of salivary glands from 131I treatment

被引：0
|
作者：
Mazokopakis, Elias E. [1 ]
机构：
[1] Naval Hosp Crete, Dept Internal Med, Khania 73200, Crete, Greece
来源：
HELLENIC JOURNAL OF NUCLEAR MEDICINE | 2018年 / 21卷 / 01期
关键词：
HASHIMOTOS-THYROIDITIS; MANAGEMENT;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [31] Predictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer
    Fard-Esfahani, Armaghan
    Valipouri, Mohammad Reza
    Harsini, Sara
    Beiki, Davood
    Emami-Ardekani, Alireza
    Fallahi, Babak
    Eftekhari, Mohammad
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2020, 28 (01): : 14 - 20
  • [32] Efficacy and Survival Analysis of 131I Therapy for Bone Metastases from Differentiated Thyroid Cancer
    Qiu, Zhong-Ling
    Song, Hong-Jun
    Xu, Yan-Hong
    Luo, Quan-Yong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10): : 3078 - 3086
  • [33] Effect of 131I treatment on parathyroid function in patients with differentiated thyroid carcinoma
    Xiao, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S586 - S587
  • [34] Evaluation of response to 131I treatment in children and adolescent with differentiated thyroid carcinoma
    Salvatori, M.
    Spitilli, M. G.
    Pizzoferro, M.
    Maussier, M. L.
    Perotti, G.
    Garganese, M. C.
    Giordano, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S342 - S343
  • [35] Sialoadenitis secondary to 131I therapy for well-differentiated thyroid cancer
    Van Nostrand, D.
    ORAL DISEASES, 2011, 17 (02) : 154 - 161
  • [36] Effect of vitamin E and supragingival scaling on salivary gland function in patients with differentiated thyroid cancer treated with 131I
    Cheng, Yan
    Tong, Huimin
    Li, Xiaoqian
    Zhang, Xiaomin
    Fang, Ju
    Yue, Rongli
    Huang, Nan
    Tian, Jing
    Yu, Feiyan
    Gao, Ying
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (09) : 995 - 1003
  • [37] Serum thyroglobulin in evaluating the response to 131I treatment in patients with distant metastatic differentiated thyroid cancer
    慕转转
    China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 130 - 131
  • [38] On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Paolo Zanotti-Fregonara
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2264 - 2266
  • [39] On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2264 - 2266
  • [40] Rare adverse effect of discontinuation of levothyroxine treatment for 131I ablation of thyroid remnant in a patient with differentiated thyroid cancer
    Luque-Ramirez, Manuel
    Gomez Ramirez, Joaquin
    Azcarate Villalon, Andrea
    Martin Perez, Elena
    Larranaga Barrera, Eduardo
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (07): : 412 - 414
12345